Oral Cancer Screening: Past, Present, and Future.
Warnakulasuriya S, Kerr AR. · 2021
Read Oral Cancer Screening: Past, Present, and Future. by Warnakulasuriya S, Kerr AR. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8529297.txt.
Introduction
Warnakulasuriya and Kerr review oral cancer screening, its past, present, and future. Oral cancer is a major public health problem that strikes more young men and women. Awareness is poor, and many patients arrive with late disease. That delay drives high death rates.
The mouth can be checked by eye, and a warning phase often shows first. Screening symptom-free people by visual exam has proved workable. A positive screen can mean cancer or a risky mouth disorder. The review covers key studies, among them one randomized trial. Screening high-risk groups pays off in cost terms. New technology may sharpen case finding soon.
Catalog record
| CREATOR | Warnakulasuriya S, Kerr AR. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Oral Cancer Screening: Past, Present, and Future By S Warnakulasuriya, AR Kerr Published in: Journal of Dental Research DOI: 10.1177/00220345211014795 ABSTRACT Abstract Oral cancer is a major public health problem, and there is an increasing trend for oral cancer to affect young men and women. Public awareness is poor, and many patients present with late-stage disease, contributing to high mortality. Oral cancer is often preceded by a clinical premalignant phase accessible to visual inspection, and thus there are opportunities for earlier detection and to reduce morbidity and mortality. Screening asymptomatic individuals by systematic visual oral examinations to detect the disease has been shown to be feasible. A positive screen includes both oral cancer and oral potentially malignant disorders. We review key screening studies undertaken, including 1 randomized clinical trial. Screening of high-risk groups is cost-effective. Strengths and weaknesses of oral cancer screening studies are presented to help guide new research in primary care settings and invigorated by the prospect of using emerging new technologies that may help to improve discriminatory accuracy of case detection. Most national organizations, including the US Preventive Services Task Force, have so far not recommended population-based screening due a lack of sufficient evidence that screening leads to a reduction in oral cancer mortality. Where health care resources are high, opportunistic screening in dental practices is recommended, although the paucity of research in primary care is alarming. The results of surveys suggest that dentists do perform oral cancer screenings, but there is only weak evidence that screening in dental practices leads to downstaging of disease. Where health care resources are low, the feasibility of using primary health care workers for oral cancer screening has been tested, and measures indicate good outcomes. Most studies reported in the literature are based on 1 round of screening, whereas screening should be a continuous process. This review identifies a huge potential for new research directions on screening for oral cancer. Keywords: cancer risk, mouth neoplasms, oral potentially malignant disorders, mass screening, clinical oral examination, case finding INTRODUCTION Recent global estimates indicate that cancers of the lip and oral cavity (referred to here as “oral cancers”) collectively represent the 16th most common malignant neoplasm worldwide, with almost 355,000 new incident cases per year (Miranda-Filho and Bray 2020). Greater than 90% of oral cancers are squamous cell carcinomas and two-thirds of cases occur in developing countries, half of which are in South Asia. India alone accounts for approximately 100,000 incident cases annually. On average, the rates for men are currently twice as high as for women, although there are exceptions, such as in Taiwan, where the male/female ratio is 10:1. The risk of developing oral cancer increases with age, and most cases occur in people over the age of 50 y. There are also wide geographical variations in incidence, with Papua New Guinea estimated as having the highest rate of oral cancer in the world. Other areas characterized by high incidence rates for oral cavity cancers are found in the South Asia (e.g., Maldives, Sri Lanka, India, and Pakistan), East Asia (e.g., Taiwan), parts of Western Europe (e.g., northeastern France and Portugal) and Eastern Europe (e.g., Hungary, Slovakia, and Slovenia), and parts of Latin America and the Caribbean (e.g., Brazil, Uruguay, and Puerto Rico) (Warnakulasuriya and Greenspan 2020). Oral cancer is linked to social and economic status and deprivation, with the highest rates occurring in the most disadvantaged sections of the population (Warnakulasuriya and Greenspan 2020). Treatment of patients with early stage oral cancer indicates that these patients have a good prognosis (Seoane et al. 2012) and improved rates of survival and quality of life. However, early stage cancers are often asymptomatic and mimic benign conditions, reducing the likelihood for the public to seek care, and therefore screening provides an opportunity for early detection. The aim of this critical review is to present the current evidence on the state of art on screening for oral cancer, to stimulate future research, policy development, and appropriate strategies to reduce deaths and suffering from oral cancer worldwide. This article consists of sections on organized programs, evaluation of their validity, adjunctive techniques, use of primary health care workers (PHCWs), e-health and mobile technology for screening, screening for human papillomavirus (HPV), predicting cancer risk models, and recommendation statements. PRINCIPLES OF SCREENING Screening has been defined as “the identification of unrecognised disease by the application of a test to people who are asymptomatic, in order to identify those who probably have the disease and to distinguish them from those who probably do not.” The criteria dictating whether a disease is “screenable” were established by Wilson and Jungner (1968), and these criteria have been expanded by national bodies (e.g., UK National Screening Committee 2003), based on new evidence and to reduce harm from screening (Appendix Table 1). Screening should be distinguished from case finding. Case finding is the term used for patients who present with abnormal signs or symptoms and undergo a diagnostic test to establish a diagnosis, in contrast to screening, which is applied to asymptomatic patients. The 2 principal benefits of cancer screening are to both “down-stage” the disease and achieve a reduction in mortality (and morbidity). In the case of oral cancer, in which the majority have a premalignant phase, screening criteria are designed to capture patients with oral cancer and oral potentially malignant disorders (OPMDs), a group of disorders with an increased risk for oral cancer (Warnakulasuriya et al. 2020). This expands the purpose of oral cancer screening to not only detect oral cancer earlier but also detect and manage those patients with OPMDs who are at risk for developing cancer. The conventional test applied in most screening studies and programs involves a systematic visual inspection and palpation of the oral cavity under a bright light source to detect abnormal oral findings that raise the index of suspicion for oral cancer or OPMDs, as well as evaluation of the neck for any enlarged lymph nodes consistent with regional metastasis. This screening test is referred to as the visual oral examination (VOE). A screening test should have the ability to select all cases with the disease among the screened population. It is important to note that a screening test is not intended to be diagnostic but aims to capture patients with such abnormal oral findings and to accelerate the referral and application of more specific diagnostic procedures by a specialist (i.e., reexamination and, if deemed necessary, diagnostic testing by tissue biopsy followed by definitive histopathological diagnosis). ORGANIZED ORAL CANCER SCREENING PROGRAMS An organized screening program consists of several essential elements, including high attendance rates, good calibration of screeners, quality control of the applied test, and availability of a referral pathway for detected cases to receive adequate treatment. These elements allow quality control, monitoring of the process, and evaluation of outcomes. Several screening models have been applied by various researchers, including population-based screening (both by home visits or by invitation to attend screening events), opportunistic screening at dental practices, integrating oral cancer screening with general health screening, screening at the place of work (e.g., industrial sites), or self-screening. Risk-based modeling to screen “at-risk” populations would seem to offer greater efficiency compared to the general population–based screening employed by